AIDSinfo E-News: Offering HIV/AIDS Research, Clinical Trials, Prevention, and Treatment Information.
|
|
AIDSinfo E-News: Offering HIV/AIDS Research, Clinical Trials, Prevention, and Treatment Information. |
|
AIDSinfo At-A-Glance Inaugural Issue No. 1 February 18, 2005 Welcome to the first issue of AIDSinfo
At-A-Glance. AIDSinfo.nih.gov is pleased to provide you with a weekly update of highlights about what has
happened in the world of HIV/AIDS treatment, prevention, and research. We hope you find this encapsulated view of
HIV/AIDS news useful.
News First annual Treatment
and Management of HIV Infection in the United States,to be held September 15-18, 2005, in Atlanta, GA.
This conference is a for all frontline clinicians providing HIV care for
adults, adolescents, children, and pregnant women. Mark your calendar now!
For more information click here, (link to pdf of general information press
release), or go to http://www.USHIVconference.org.
More
Powerful HIV Strain Found A virulent strain of HIV resistant to most antiviral
drugs and progresses from infection to full-blown AIDS within two or three
months has been identified for the first time, in a New York City
resident-February 12, 2005. See full story in MedlinePlus: http://www.nlm.nih.gov/medlineplus/news/fullstory_22918.html. Request
for Applications (RFA) to Establish Clinical Trials Units A series of pre-application meetings will be held for
representatives of institutions that would like to learn more about the
Request for Applications (RFA) to establish Clinical Trials Units (CTUs)
as part of the HIV/AIDS Clinical Trials Networks of the U.S. National
Institutes of Health’s Division of AIDS (NIH/DAIDS).
(link to NIAID pdf) Drug
Info Roche
Laboratories Inc. issues "Dear Health Care Provider" letter
to communicate important drug interaction warning for
saquinavir/ritonavir, used as part of combination therapy for treatment of
HIV infection. Read FDA's listserv message for the full story-February 8,
2005. (link to pdf of FDA list serv) Press Releases International Trial of Two Microbicides Begins:
A large, multisite trial designed to examine the
safety and preliminary effectiveness of two candidate topical microbicides
to prevent HIV infection has opened to volunteer enrollment. Read the full
story in National Institutes of Health press release-February 11, 2005: http://www2.niaid.nih.gov/newsroom/Releases/2microbicides.htm ClinicalTrials.gov Info New clinical trial records For the most recent HIV/AIDS clinical trials listed
on Clinical Trials.gov click here: Many thanks to our information partners at Centers
for Disease Control and Prevention; Clinical Trials.gov; National
Institutes of Health: National Institute of Allergy and Infectious
Diseases, National Institute of Mental Health, NIH, Office of AIDS
Research; Department of Health and Human Services; and the FDA for their
vigilance in keeping AIDSinfo informed about
developments in a timely way so that we can share the information with our
readers while it's relevant. Please send comments or suggestions to ContactUs@aidsinfo.nih.gov
AIDSinfo Live Help "write-in" service For individualized assistance with any questions regarding the guidelines or other HIV/AIDS-related research, clinical trials, and treatment, try our Live Help service at http://aidsinfo.nih.gov/live_help. This service provides real time, online assistance with a Health Information Specialist and is available Monday - Friday, 12:00 p.m. (Noon) - 4:00 p.m. Eastern Time. |
|
You are currently subscribed to %%list.name%% as: %%emailaddr%% |
|
For access to Federal HIV/AIDS information on clinical research, HIV treatment
and prevention, and medical practice guidelines for health care providers and
consumers, visit the AIDSinfo web
site or
You may also contact our Help Line. English- and Spanish-speaking Health Information Specialists are available Monday - Friday, 12:00 p.m. (Noon) - 5:00 p.m. Eastern time. Telephone: 800-448-0440 |